# Verbenalin

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/verbenalin
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-03-30
**Evidence Score:** 4 / 10
**Category:** Compound
**Also Known As:** Vervain glycoside, Verbena officinalis extract compound, Iridoid verbenalin, Verbenalin iridoid glycoside, Holy herb compound, European vervain extract, Verbenaceae iridoid, Traditional vervain active compound

## Overview

Verbenalin is an iridoid glycoside found primarily in Verbena officinalis that exerts [neuroprotective](/ingredients/condition/cognitive) and organ-protective effects through modulation of [oxidative stress](/ingredients/condition/antioxidant) pathways and [inflammatory](/ingredients/condition/inflammation) signaling. Its primary mechanisms involve inhibition of ferroptosis, upregulation of HIF-1α/HO-1 antioxidant pathways, and restoration of neurotrophic factor expression including BDNF in hippocampal tissue.

## Health Benefits

• May protect kidney function during ischemia-reperfusion injury by inhibiting ferroptosis and upregulating HIF-1α/HO-1 pathways (preliminary animal evidence)
• Potentially reduces Alzheimer's disease markers including amyloid-beta and tau proteins while restoring [BDNF](/ingredients/condition/cognitive) levels in the hippocampus (preliminary animal evidence)
• May alleviate alcoholic liver damage by targeting [oxidative stress](/ingredients/condition/antioxidant) and [mitochondrial](/ingredients/condition/energy) dysfunction via MDMX/PPARα pathways (preliminary animal evidence)
• Could protect against acute lung injury by suppressing [inflammatory](/ingredients/condition/inflammation) pyroptosis and NET formation through GPR18 receptor activation (preliminary animal evidence)
• May enhance natural killer (NK) cell efficiency by shortening target contact time without affecting proliferation (preliminary in-vitro evidence)

## Mechanism of Action

Verbenalin activates the HIF-1α/HO-1 signaling axis, which suppresses ferroptosis — an iron-dependent form of programmed cell death — by reducing [lipid peroxidation](/ingredients/condition/antioxidant) and preserving [mitochondrial](/ingredients/condition/energy) integrity in renal tubular cells. In neurological contexts, verbenalin appears to inhibit beta-secretase (BACE1) activity and tau hyperphosphorylation, reducing amyloid-beta plaque accumulation while simultaneously upregulating [BDNF](/ingredients/condition/cognitive)/TrkB signaling in the hippocampus. It also modulates NF-κB-driven neuroinflammation by downregulating [pro-inflammatory cytokine](/ingredients/condition/inflammation)s including TNF-α and IL-1β.

## Clinical Summary

Current evidence for verbenalin is largely preclinical, derived from rodent models of ischemia-reperfusion injury and Alzheimer's disease rather than human clinical trials. In animal studies, verbenalin administration reduced serum creatinine and BUN markers of kidney injury by approximately 30–50% in ischemia-reperfusion models, with histological evidence of reduced tubular necrosis. Alzheimer's model rodents treated with verbenalin showed measurable decreases in hippocampal amyloid-beta deposits and improved Morris water maze performance, suggesting [cognitive](/ingredients/condition/cognitive) benefit. No peer-reviewed human randomized controlled trials have been published as of early 2025, making translation of these findings to clinical practice premature.

## Nutritional Profile

Verbenalin (also known as verbenalol glucoside or cornin) is an iridoid glycoside, not a nutritional food source. It is a secondary plant metabolite and therefore does not possess a conventional macronutrient or micronutrient profile. Key biochemical details: • Chemical formula: C₁₇H₂₄O₁₀ • Molecular weight: ~388.37 g/mol • Classification: Iridoid glycoside (monoterpene-derived) • Primary natural sources: Verbena officinalis (common vervain), Verbena hastata (blue vervain), and Cornaceae species; typically present in aerial parts at concentrations ranging from approximately 0.1–2.0% dry weight depending on plant species, harvest time, and extraction method • Bioactive compound characteristics: Contains a glucose moiety linked to an iridoid aglycone (verbenalol); the glycosidic bond is hydrolyzed by intestinal β-glucosidases, releasing the active aglycone for absorption • Bioavailability notes: As an iridoid glycoside, oral bioavailability is generally considered low to moderate; the compound undergoes extensive first-pass [metabolism](/ingredients/condition/weight-management) and intestinal hydrolysis; the sugar moiety (glucose) enhances water solubility but may limit passive membrane permeation; studies suggest absorption is improved when administered in whole-plant extracts containing other polyphenols and organic acids that may modulate gut permeability and transporter activity • No meaningful content of macronutrients (protein, fat, carbohydrates, fiber), vitamins, or dietary minerals, as it is consumed in milligram-level pharmacological doses rather than as a food • Often co-occurs in plant extracts with other bioactive iridoids (hastatoside, aucubin), flavonoids (apigenin, luteolin), and phenylpropanoids (acteoside/verbascoside), which may contribute synergistic biological effects • Typical experimental doses in animal studies range from approximately 5–100 mg/kg body weight; no established human dietary reference intake or recommended dosage exists

## Dosage & Preparation

No human dosage data exists. Animal studies used 10-20 mg/kg daily for kidney protection, 100-200 mg/kg for Alzheimer's models, with administration routes including oral gavage and intraperitoneal injection. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

Verbenalin has not undergone formal human safety trials, so a comprehensive side effect profile has not been established. Animal studies have not reported overt toxicity at studied doses, but high-dose iridoid glycosides as a class can cause gastrointestinal irritation in some individuals. Verbenalin may theoretically potentiate anticoagulant medications such as warfarin due to its effects on oxidative and [inflammatory pathway](/ingredients/condition/inflammation)s, though direct interaction data are lacking. Pregnant and breastfeeding women should avoid verbenalin supplements due to the absence of safety data, and individuals with iron [metabolism](/ingredients/condition/weight-management) disorders should use caution given its ferroptosis-modulating activity.

## Scientific Research

No human clinical trials, randomized controlled trials, or meta-analyses have been conducted on verbenalin; all available evidence comes from preclinical animal and cell studies. Key animal studies include mouse models of kidney injury (PMID: 41286690), sepsis-induced lung injury (PMID: 37315751), and alcoholic steatohepatitis (PMID: 36739928), with doses ranging from 10-200 mg/kg.

## Historical & Cultural Context

Verbena officinalis, the source of verbenalin, has been used in traditional Chinese medicine (including modern COVID-19 formulations like Xuanfeibaidu granules) and European herbalism for [inflammation](/ingredients/condition/inflammation), liver conditions, respiratory issues, and infections. Historical applications include treating jaundice, edema, malaria, dysmenorrhea, and throat obstruction.

## Synergistic Combinations

HIF-1α activators, [BDNF](/ingredients/condition/cognitive) enhancers, PPARα agonists, GPX4 supporters, [Antioxidant](/ingredients/condition/antioxidant)s

## Frequently Asked Questions

### What plant does verbenalin come from?

Verbenalin is the primary iridoid glycoside extracted from Verbena officinalis, commonly known as common vervain or herb of grace. It is concentrated in the aerial parts of the plant, including leaves and stems, and has been used in traditional European and Chinese herbal medicine for centuries. Smaller amounts are also found in related Verbena and Lippia species.

### Can verbenalin help with Alzheimer's disease?

Preliminary rodent studies suggest verbenalin may reduce two hallmark Alzheimer's biomarkers — amyloid-beta plaques and hyperphosphorylated tau proteins — while restoring BDNF levels in the hippocampus, a brain region critical for memory. These effects appear to be mediated partly through inhibition of BACE1 enzyme activity and suppression of neuroinflammatory NF-κB signaling. However, no human clinical trials exist, so these findings cannot yet be applied as a treatment recommendation.

### How does verbenalin protect the kidneys?

Verbenalin has demonstrated renal protective effects in animal models of ischemia-reperfusion injury, a condition where blood flow is restored to the kidney after a period of deprivation, causing oxidative damage. It works by upregulating the HIF-1α/HO-1 pathway, which increases cellular antioxidant defenses and inhibits ferroptosis — an iron-driven cell death process that damages renal tubular cells. In these models, treated animals showed significantly lower kidney injury markers including serum creatinine and blood urea nitrogen (BUN).

### What is the typical dosage of verbenalin?

No standardized human dosage for verbenalin has been established because clinical trials in humans have not been conducted. Animal studies have typically used doses ranging from 10 to 50 mg/kg body weight administered orally or intraperitoneally, which does not directly translate to human supplementation guidelines. Commercial verbenalin or Verbena officinalis extracts vary widely in verbenalin content, and consumers should exercise caution when interpreting label claims without standardized potency verification.

### Is verbenalin the same as verbenin or verbenaline?

Verbenalin (also called cornin) is chemically distinct from verbenaline, which is an alkaloid found in some Verbena species, so these two compounds should not be confused. Verbenalin is an iridoid glycoside with the molecular formula C₁₇H₂₄O₁₀, whereas verbenaline is a pyridine alkaloid with entirely different pharmacological properties. The naming similarity causes frequent confusion in supplement labeling, and consumers should verify the compound class — iridoid glycoside versus alkaloid — when evaluating a product.

### What does current research show about verbenalin's effectiveness in humans?

Most evidence for verbenalin comes from preliminary animal studies examining kidney protection, cognitive benefits, and liver health support. Clinical trials in humans are limited, so efficacy in human populations remains largely unestablished. Current research suggests potential promise for ferroptosis inhibition and neuroprotection, but larger, well-designed human studies are needed before definitive claims can be made about its therapeutic value.

### Is verbenalin safe to take with common medications?

There is insufficient clinical data on verbenalin's interactions with medications because human studies remain limited. Given its effects on oxidative stress pathways and potential modulation of cellular signaling, individuals taking medications for liver disease, kidney conditions, or neurological disorders should consult a healthcare provider before supplementing. Drug interaction testing has not been systematically performed for verbenalin in human populations.

### What is the bioavailability of verbenalin and how is it best absorbed?

Limited data exists on verbenalin's absorption, metabolism, and bioavailability in humans. Animal studies suggest it may cross the blood-brain barrier to reach the hippocampus, indicating reasonable CNS penetration, though the specific factors affecting its absorption remain unclear. Whether verbenalin should be taken with food or on an empty stomach for optimal absorption has not been established through clinical research.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*